Immuneering Corp Quarterly Debt-to-equity in % from Q1 2022 to Q3 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Immuneering Corp quarterly Debt-to-equity history and growth rate from Q1 2022 to Q3 2024.
Immuneering Corp Debt-to-equity for the quarter ending September 30, 2024 was 14.6 %, a 48.3% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	14.6	+4.76	+48.3%	Sep 30, 2024
Q2 2024	12.3	+2.44	+24.7%	Jun 30, 2024
Q1 2024	10.5	+1.32	+14.3%	Mar 31, 2024
Q4 2023	10.2	+2.12	+26.2%	Dec 31, 2023
Q3 2023	9.86	+2.77	+39.1%	Sep 30, 2023
Q2 2023	9.9	+4.27	+75.9%	Jun 30, 2023
Q1 2023	9.22	+2.08	+29.1%	Mar 31, 2023
Q4 2022	8.08			Dec 31, 2022
Q3 2022	7.09			Sep 30, 2022
Q2 2022	5.63			Jun 30, 2022
Q1 2022	7.14			Mar 31, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.